FDA Cuts Gap for Moderna COVID-19 Booster Dose to Five Months

Published on January 7, 2022

The U.S. Food and Drug Administration said on Friday it shortened the interval between the primary series of the Moderna COVID-19 vaccine and a booster dose by a month for people aged 18 or above to at least five months. “Vaccination is our best defense against COVID-19,…

Read Full Article (External Site)